From the Editor

The Price Debate

February 02, 2022

As company revenues are gaining a boost from COVID-19, the issue of pricing is being debated once more.

Celebrate the New

February 02, 2022

The process of reshaping inevitably leads to fresh insights.

Hot Picks for 2022

January 02, 2022

Overall, 2021 proved to be another good year for drug approvals in Europe, albeit with a slight disappointment for Alzheimer’s patients, but what should industry be watching out for in 2022?

January Makes Your Head Spin

January 02, 2022

January is the kind of month that can make your head spin.

Spinning Success? The Benefits of University Spinouts

December 02, 2021

Pharma and biotech are ruling the roost in terms of university innovation, but European spinouts are still experiencing barriers to long-term success.

Breaking the Rules

December 02, 2021

We have broken rules, invented new ones, and engineered stronger institutions and supply chains that will serve us better going forward.

Great Expectations for Excipients

November 02, 2021

Can We Agree on Conferences?

November 02, 2021

Making a Difference in European Bio/Pharma

November 02, 2021

Manufacturing capacity expansion is high on the agenda for many bio/pharma companies and service providers in Europe.

New Beginnings

October 02, 2021

Change of roster does not change the goal line. We are all patients first.